Gout: Treat to Target From the College | October 18, 2022 The gout research presented at ACR Convergence 2021 had a broad scope. Review our article, "Research Roundup: Abstract Data Presented at ACR Convergence 2021" for highlights from three of the studies presented. According to research from Yoshida et al., a treat-to-target approach was associated with a reduction in which of the following outcomes, compared with initiation of urate-lowering therapy without treating to target? A. Cancer risk B. Major adverse coronary events C. Chronic kidney disease D. All of the above None Time's up
